Skip to content
Wednesday, 18 November 2026
Inspire.News

Unveiling truth, one story at a time

Two Bundibugyo‑Targeted Ebola Vaccines to Begin Phase‑2 Trials in DRC

Two Bundibugyo‑Targeted Ebola Vaccines to Begin Phase‑2 Trials in DRC
Image: Kenya Today

Oxford‑Moderna and Oxford‑Serum Institute candidates will start Phase‑2 testing in Bunia next week, marking a key step against the Bundibugyo Ebola strain.

Full story

Continue reading this story on Kenya Today, the publisher that reported it.

Read the full story at Kenya Today ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from National · Kenya

See all